This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 15 - 18, 2024
Marriott Marquis San DiegoLive In-Person Event: December 15 - 18, 2024

David Kugler, Ph.D.
Vice President of Immunology at Cartography Biosciences


Dr. Kugler currently serves as Vice President of Research and Early Development at Cartography Biosciences, where he leads pipeline development translating comprehensive antigen profiling into immune-based therapies. Prior to Cartography, he was a Scientific Director at Bristol-Myers Squibb (formally Juno Therapeutics and Celgene) where he contributed to bringing multiple early programs to the clinic. Throughout his career, Dr. Kugler has studied immune regulation within the contexts of autoimmunity, infectious diseases, and cancer and his expertise spans multiple disciplines including computational biology, functional genomics, immunology, pharmacology, and the drug development of biologics and cell therapies. Dr. Kugler holds a PhD from Johns Hopkins University, in collaboration with the National Institutes for Allergy and Infectious Disease (NIAID) at NIH, and completed postdoctoral training at NIAID/NIH as well as Benaroya Research Institute.

Agenda Sessions

  • Identifying Optimal Targets and Target Pairs for Multi-specific Targeted Therapies